----- forwarded -----

The following deal with growing problems around antibiotic and vaccine supplies

The Infectious Diseases Society of America (IDSA) has just embarked on a large
advocacy and public awareness program to point out that the situation for
antibiotics is as dire as the vaccine situation.  IDSA research indicates that
of 360 or so drugs now in the entire clinical R&D pipeline of pharma in the US,
only 5 are new antibiotic moieties.

See <www.idsociety.org>  Bad Bugs, No Drugs

There was an editorial in Lancet Infectious Diseases (LID) recently that
examined the question of why vaccine shortages occurred. Reasons
for shortages advanced by LID are all economic i.e. there is
insufficient financial incentive for manufactures to remain in the
vaccine business.

Shortages have become more common as the number of US
manufacturers has decreased from 25 to just 5 in the past 30 years;
during the period 1998-2001 10 out of 14 producers globally of routine
childhood vaccines stopped production. The LID suggests some remedies
for this problem, again all economic.

----- End forwarded material -----
Forwarded by Sam Lanfranco, CLICK4HP Host/Co-Admin

To unsubscribe from CANCHID send: unsubscribe CANCHID to: [log in to unmask]  -  for help see http://listserv.yorku.ca